Start improving your cell performance today
A new narrative review in the International Journal of Dermatology examines GLP-1 receptor agonists and dual GIP/GLP-1 agonists as adjunctive therapies for patients with HS and overweight, obesity, or type 2 diabetes
Studies, predominantly in animal models, have explored its effects on wound healing, tendon and ligament repair, gut health, and neuroprotection
In this series, youll hear from three dietitians who regularly work with GLP-1 agonists and each bring a unique clinical and personal perspective to the conversation
This advanced delivery system creates microscopic spheres that protect glutathione molecules from digestive degradation while facilitating direct cellular uptake
You may not want to continue your exercise routine full force until you adjust to your medication